Pegasus Partners Ltd. Sells 695 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pegasus Partners Ltd. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,442 shares of the healthcare conglomerate’s stock after selling 695 shares during the period. Pegasus Partners Ltd.’s holdings in UnitedHealth Group were worth $4,936,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Carson Advisory Inc. increased its position in UnitedHealth Group by 7.4% in the third quarter. Carson Advisory Inc. now owns 1,119 shares of the healthcare conglomerate’s stock worth $654,000 after buying an additional 77 shares in the last quarter. Rovin Capital UT ADV bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $239,000. Executive Wealth Management LLC raised its position in shares of UnitedHealth Group by 6.6% during the 3rd quarter. Executive Wealth Management LLC now owns 1,088 shares of the healthcare conglomerate’s stock valued at $636,000 after purchasing an additional 67 shares during the period. Windward Capital Management Co. CA increased its stake in UnitedHealth Group by 181.8% in the 3rd quarter. Windward Capital Management Co. CA now owns 1,195 shares of the healthcare conglomerate’s stock worth $699,000 after buying an additional 771 shares in the last quarter. Finally, Provident Trust Co. grew its holdings in UnitedHealth Group by 0.5% during the 3rd quarter. Provident Trust Co. now owns 632,617 shares of the healthcare conglomerate’s stock valued at $369,879,000 after buying an additional 2,936 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on UNH. Argus raised their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Truist Financial restated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Trading Up 1.8 %

UnitedHealth Group stock opened at $616.33 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $619.80. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a market cap of $567.20 billion, a PE ratio of 40.15, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. The stock has a 50-day moving average of $581.93 and a two-hundred day moving average of $545.03.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.56 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.